HomeLiterature Search
Popular searches
Common genetic variants in the microRNA biogenesis pathway are associated with …

Weng(Yuxiong),Chen(Yanhua),Chen(Jianghai),Li… Cancer Epidemiol 2014-07-24

...NF1 and 156 patients with both NF1 and MPNST) in China. Association analysis was performed in an additive genetic model ...

Plasma S100β is not a useful biomarker for tumor burden in neurofibromatosis.

Smith(Miriam J),Esparza(Sonia),Merker(Vaness… Clin Biochem 2013-09-30

Neurofibromatosis 1 (NF1), NF2, and schwannomatosis are characterized by a predisposition to develop multiple neurofibro...

Back to the future: proceedings from the 2010 NF Conference.

Huson(SM),Acosta(MT),Belzberg(AJ),Bernards(A… Am J Med Genet A 2011-02-00

The neurofibromatoses (NF) encompass the rare diseases NF1, NF2, and schwannomatosis. The NFs affect 100,000 Americans; ...

Soluble AXL: a possible circulating biomarker for neurofibromatosis type 1 rela…

Johansson(Gunnar),Peng(Po-Chun),Huang(Po-Yua… PLoS One 2015-10-01

Neurofibromatosis type 1 (NF1) is the most common tumor predisposition disorder affecting 1/3500 worldwide. Patients are...

Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral ner…

Miller(SJ),Lan(ZD),Hardiman(A),Wu(J),Kordich… Oncogene 2010-01-21

...NF1) patients, subsequent to NF1 mutation, we found that exogenous expression of the NF1-GTPase activating protein-relat...

Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK fa…

Evans(DG),Howard(E),Giblin(C),Clancy(T),Spen… Am J Med Genet A 2010-02-00

...NF1); 16% (FAP); 26% (GS); 56% (NF2); and 21% (VHL). Estimates for NF1, NF2, FAP, and VHL are in line with previous esti...

Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-…

Bittner(M),Llaurado Fernandez(M),Hoenisch(J)… Int J Mol Sci 2026-02-12

...NF1 and displayed low pRb levels. Palbociclib showed limited efficacy in vitro; however, the combination of palbociclib ...

Multifocal malignant peripheral nerve sheath tumor in patients with neurofibrom…

Salem(RH),Almutairi(OT),Bafaquh(MS) Surg Neurol Int 2023-00-00

...NF1). Almost 81% of MPNST arises from a precursor neuroma, and multifocality of these lesions is extremely rare, making ...

Selumetinib in the treatment of plexiform neurofibromas in neurofibromatosis ty…

Baldo(F),Messana(L),Andresani(A),Magnolato(A… BMC Pediatr 2026-06-08

...NF1. This is a prospective case series that describes the patients affected by NF1 with inoperable, symptomatic, or disf...

Induced pluripotent stem cell-derived models of malignant nerve sheath tumor pr…

Uriarte-Arrazola(I),Magallón-Lorenz(M),Ferná… Nat Commun 2026-06-17

Neurofibromatosis Type 1 (NF1) predisposes to peripheral nerve tumor development. The progression from a benign plexifor...

Previous 491 492 493 494 495 496 497 498 499 Next Vol. 495 / of 895 页

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com